RRM1 anticorps (N-Term)
Aperçu rapide pour RRM1 anticorps (N-Term) (ABIN630191)
Antigène
Voir toutes RRM1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- RRM1 antibody was raised against the N terminal of RRM1
-
Purification
- Purified
-
Immunogène
- RRM1 antibody was raised using the N terminal of RRM1 corresponding to a region with amino acids ATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHL
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RRM1 Blocking Peptide, (ABIN936944), is also available for use as a blocking control in assays to test for specificity of this RRM1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RRM1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RRM1 (Ribonucleotide Reductase M1 (RRM1))
-
Autre désignation
- RRM1
-
Sujet
- RRM1 is one of two non-identical subunits that constitute ribonucleoside-diphosphate reductase, an enzyme essential for the production of deoxyribonucleotides prior to DNA synthesis in S phase of dividing cells. Its gene is located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. Its gene may play a role in malignancies and disease that involve this region.
-
Poids moléculaire
- 90 kDa (MW of target protein)
-
Pathways
- Positive Regulation of Endopeptidase Activity
Antigène
-